BST1 gene

Known as: ADP-ribosyl cyclase 2, NAD(+) nucleosidase, CD157 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2017
024619882017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
CD157, also referred to as bone marrow stromal cell antigen-1 (BST-1), is a glycosylphosphatidylinositol-anchored molecule that… (More)
Is this relevant?
2014
2014
CD157/BST-1 behaves both as an ectoenzyme and signaling receptor and is an important regulator of leukocyte trafficking and… (More)
Is this relevant?
2013
2013
Background: Recent Flow Cytometric guidelines to detect Paroxysmal Nocturnal Hemoglobinuria (PNH) in white blood cells recommend… (More)
Is this relevant?
2011
2011
To date, nine Parkinson disease (PD) genome-wide association studies in North American, European and Asian populations have been… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
In view of the population-specific heterogeneity in reported genetic risk factors for Parkinson's disease (PD), we conducted a… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2011
2011
CD157, a member of the CD38 gene family, is an NAD-metabolizing ectoenzyme and a signaling molecule whose role in polarization… (More)
Is this relevant?
2009
2009
Nicotinamide adenine dinucleotide (NAD(+)), a precursor of molecules involved in cell regulatory processes, is released in extra… (More)
Is this relevant?
2006
2006
Increased numbers of endothelial cells are observed in peripheral blood of cancer patients. These circulating endothelial cells… (More)
  • figure 1
  • figure 2
Is this relevant?
2004
2004
CD157, a glycosylphosphatidylinositol (GPI)-anchored protein encoded by a member of the CD38 NADase/ADP-ribosyl cyclase gene… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Sphingolipids elicit a wide variety of eukaryotic cellular responses, most involving regulation of cell growth, differentiation… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?